To this end, we examined the protein expression of ABCB1 in KB-V-1 cancer cells and ABCG2 in S1-M1-80 cancer cells by immunoblotting after treating cells with sitravatinib at various concentrations (100–500 nM) for 72 h as described in Materials and Methods. The gene discussed is ABCG2; the disease is cancer.